5 NASH Clinical Trials in Canoga Park, CA (2026)

Q: How do I join a clinical trial in Canoga Park?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Canoga Park research site will contact you.

Recruiting NASH Studies in Canoga Park

NCT07165028Recruiting

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

The main purpose of the SYNERGY-OUTCOMES study is to find out whether retatrutide and tirzepatide can prevent major adverse liver outcomes (MALO) in people with high-risk metabolic dysfunction-associa...

Canoga Park, CA4,500 participantsEli Lilly and Company

View Study Details

NCT06632444Recruiting

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

This study is open to adults who are at least 18 years old living with obesity and have: * a confirmed liver disease called non-alcoholic steatohepatitis (NASH)/metabolic associated steatohepatitis (...

Canoga Park, CA1,800 participantsBoehringer Ingelheim

View Study Details

NCT06632457Recruiting

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

This study is open to adults who are at least 18 years old and have: * A confirmed liver disease called non-alcoholic steatohepatitis (NASH) or * A confirmed liver disease called metabolic-associated...

Canoga Park, CA1,590 participantsBoehringer Ingelheim

View Study Details

NCT06318169Recruiting

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

The study will assess the efficacy and safety of 2 dose regimens of pegozafermin for the treatment of liver fibrosis stage 2 or 3 in adult participants with MASH (previously known as nonalcoholic stea...

Canoga Park, CA1,350 participants89bio, Inc.

View Study Details

NCT05519475Recruiting

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

This study is researching an investigational drug, ALN-HSD called "study drug". This study is focused on participants who are known to have metabolic dysfunction-associated steatohepatitis (MASH). MAS...

Canoga Park, CA120 participantsRegeneron Pharmaceuticals

View Study Details

About NASH Clinical Trials in Canoga Park

Nonalcoholic steatohepatitis (NASH/MASH) is a form of fatty liver disease involving liver inflammation and damage caused by fat buildup, not related to alcohol use. It can progress to fibrosis, cirrhosis, and liver failure. Treatment focuses on weight loss, lifestyle changes, and emerging pharmacological therapies.

There are currently 5 nash clinical trials recruiting participants in Canoga Park, CA. These studies are seeking a combined 9,360 participants. Research is being sponsored by Eli Lilly and Company, Boehringer Ingelheim, 89bio, Inc. and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

NASH Clinical Trials in Canoga Park — FAQ

Are there nash clinical trials in Canoga Park?

Yes, there are 5 nash clinical trials currently recruiting in Canoga Park, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Canoga Park?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Canoga Park research site will contact you about next steps.

Are clinical trials in Canoga Park free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Canoga Park studies also compensate for your time and travel.

What nash treatments are being tested?

The 5 active trials in Canoga Park are testing new therapies including novel drugs, biologics, and treatment approaches for nash.

Data updated July 13, 2026 from ClinicalTrials.gov